Literature DB >> 22465996

Nkx3.1 functions as para-transcription factor to regulate gene expression and cell proliferation in non-cell autonomous manner.

Jian Zhou1, Li Qin, Jean Ching-Yi Tien, Li Gao, Xian Chen, Fen Wang, Jer-Tsong Hsieh, Jianming Xu.   

Abstract

Nkx3.1 is a homeoprotein transcription factor (TF) that inhibits proliferation of prostate epithelial cells (PECs) and acts as a tumor suppressor for prostate cancer (PCa). Because TFs classically function within the cells that produce them, Nkx3.1-induced growth inhibition was considered to occur in a cell-autonomous manner. We, however, found that Nkx3.1 protein can be secreted from cultured PECs and is detectable in the prostatic fluid and urine. A PCa-related point mutation (T164A) abolished Nkx3.1 secretion. Amazingly, secreted Nkx3.1 protein can translocate into adjacent cells, bind to the regulatory sequence of Nkx3.1 target genes and impact the expression of these genes in these adjacent cells. Expression of Nkx3.1 in PECs can also affect gene expression in adjacent cells, and this effect is abolished by the T164A mutation. Nkx3.1 protein inhibits cell proliferation when added to the culture. Expression of Nkx3.1, not the T164A mutant, also inhibits the proliferation of co-cultured cells. These results indicate that Nkx3.1 functions as a "para-transcription factor (PTF)," with the ability to regulate genes and inhibit cell proliferation in a non-cell autonomous manner. We also demonstrate that Nkx3.1 contains an evolutionarily conserved protein transduction domain essential for its PTF function, implicating potentially common PTF function among homeoproteins. In addition to the PCa-related T164A mutant, the secreted Nkx3.1 is reduced drastically in the prostatic fluid and urine of mice with PCa. These results indicate that Nkx3.1 can function as a PTF to suppress PCa and the urinary Nkx3.1 may be a potential biomarker for PCa diagnosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22465996      PMCID: PMC3366845          DOI: 10.1074/jbc.M111.336909

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Haploinsufficiency at the Nkx3.1 locus. A paradigm for stochastic, dosage-sensitive gene regulation during tumor initiation.

Authors:  Jeffrey A Magee; Sarki A Abdulkadir; Jeffrey Milbrandt
Journal:  Cancer Cell       Date:  2003-03       Impact factor: 31.743

2.  Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer.

Authors:  L L Xu; V Srikantan; I A Sesterhenn; M Augustus; R Dean; J W Moul; K C Carter; S Srivastava
Journal:  J Urol       Date:  2000-03       Impact factor: 7.450

3.  Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis.

Authors:  Minjung J Kim; Rajula Bhatia-Gaur; Whitney A Banach-Petrosky; Nishita Desai; Yuzhuo Wang; Simon W Hayward; Gerald R Cunha; Robert D Cardiff; Michael M Shen; Cory Abate-Shen
Journal:  Cancer Res       Date:  2002-06-01       Impact factor: 12.701

4.  Analysis of oligo-arginine cell-permeable peptides uptake by prostate cells.

Authors:  Jian Zhou; Wei Liu; Rey-Chen Pong; Guiyang Hao; Xiankai Sun; Jer-Tsong Hsieh
Journal:  Amino Acids       Date:  2010-12-01       Impact factor: 3.520

5.  Expression studies and mutational analysis of the androgen regulated homeobox gene NKX3.1 in benign and malignant prostate epithelium.

Authors:  D K Ornstein; M Cinquanta; S Weiler; P H Duray; M R Emmert-Buck; C D Vocke; W M Linehan; J A Ferretti
Journal:  J Urol       Date:  2001-04       Impact factor: 7.450

6.  Expression of NKX3.1 in normal and malignant tissues.

Authors:  Edward P Gelmann; Cai Bowen; Lukas Bubendorf
Journal:  Prostate       Date:  2003-05-01       Impact factor: 4.104

7.  Hoxb13 is required for normal differentiation and secretory function of the ventral prostate.

Authors:  Kyriakos D Economides; Mario R Capecchi
Journal:  Development       Date:  2003-05       Impact factor: 6.868

8.  Nkx3.1, a murine homolog of Ddrosophila bagpipe, regulates epithelial ductal branching and proliferation of the prostate and palatine glands.

Authors:  M Tanaka; I Komuro; H Inagaki; N A Jenkins; N G Copeland; S Izumo
Journal:  Dev Dyn       Date:  2000-10       Impact factor: 3.780

9.  Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression.

Authors:  C Bowen; L Bubendorf; H J Voeller; R Slack; N Willi; G Sauter; T C Gasser; P Koivisto; E E Lack; J Kononen; O P Kallioniemi; E P Gelmann
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

10.  Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia.

Authors:  Sarki A Abdulkadir; Jeffrey A Magee; Thomas J Peters; Zahid Kaleem; Cathy K Naughton; Peter A Humphrey; Jeffrey Milbrandt
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

View more
  4 in total

Review 1.  The role of epigenetic-related codes in neurocomputation: dynamic hardware in the brain.

Authors:  Lawrence Edelstein; John Smythies
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-09-26       Impact factor: 6.237

Review 2.  Peptide-Based Therapeutics for Oncology.

Authors:  Elizaveta Fisher; Kirill Pavlenko; Alexander Vlasov; Galina Ramenskaya
Journal:  Pharmaceut Med       Date:  2019-02

Review 3.  Recent advances in prostate development and links to prostatic diseases.

Authors:  Ginny L Powers; Paul C Marker
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2013-01-17

4.  Control of brain patterning by Engrailed paracrine transfer: a new function of the Pbx interaction domain.

Authors:  Christine Rampon; Carole Gauron; Thibault Lin; Francesca Meda; Edmond Dupont; Adrien Cosson; Eliane Ipendey; Alice Frerot; Isabelle Aujard; Thomas Le Saux; David Bensimon; Ludovic Jullien; Michel Volovitch; Sophie Vriz; Alain Joliot
Journal:  Development       Date:  2015-04-29       Impact factor: 6.868

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.